Concepedia

S O'Brien

SO

Statistics

Publications

4

Citations

342

H-Index

4

Active since

1991

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

S O'Brien is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, hematology, and immunology.

Top concepts

Publications per year

1991–2000

4

Publications

4

Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.

Michael J. Keating, H. Kantarjian, S O'Brien et al. · Journal of Clinical Oncology · 1991 · 249 citations

, , +18

High-dose rituximab therapy in chronic lymphocytic leukemia.

Michael R. Keating, S O'Brien · PubMed · 2000 · 42 citations

A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemia.

L. E. Robertson, S O'Brien, Hagop M. Kantarjian et al. · PubMed · 1995 · 32 citations

Serum beta-2 microglobulin levels are a significant prognostic factor in Philadelphia chromosome-positive chronic myelogenous leukemia.

Jessica Rodriguez, Jörge E. Cortes, Moshe Talpaz et al. · PubMed · 2000 · 19 citations

, , +14

1–4 of 4